Suppr超能文献

与CP20相比,羟基吡啶酮CP411在正常和转化大鼠肝细胞培养物中的铁动员、细胞保护及细胞增殖抑制作用:一项生物学和物理化学研究

Iron mobilization, cytoprotection, and inhibition of cell proliferation in normal and transformed rat hepatocyte cultures by the hydroxypyridinone CP411, compared to CP20: a biological and physicochemical study.

作者信息

Gaboriau François, Chantrel-Groussard Karine, Rakba Nafissa, Loyer Pascal, Pasdeloup Nicole, Hider Robert C, Brissot Pierre, Lescoat Gérard

机构信息

Inserm U 522, Equipe: "Foie, fer et autres métaux", CHU de Rennes, Hôpital Pontchaillou, Rennes, France.

出版信息

Biochem Pharmacol. 2004 Apr 15;67(8):1479-87. doi: 10.1016/j.bcp.2003.12.019.

Abstract

The present study analyzes the iron mobilization, the cytoprotective, and the antiproliferative effects of the lipophilic hydroxypyridinone CP411, in comparison with the hydrophilic chelator CP20 or deferiprone used in the treatment of iron overload. Primary rat hepatocyte cultures and the rat hepatoma cell line Fao were used. Chelator cell uptake was evaluated by mass spectrometry in the two models. This method was also used to investigate the stability of the chelators in an acellular system as well as their scavenging and chelating effects against the hydroxyl radical generated by the Fenton reaction. The iron mobilization and the cytoprotective effects of the chelators were evaluated in primary cultures by measuring respectively 55Fe and lactate dehydrogenase release in the culture medium. The antiproliferative effect of the chelators was studied using the Fao cell line and measuring DNA synthesis by thymidine incorporation and DNA content by flow cytometry. We observed that CP411 entered the hepatocytes and the Fao cells respectively 4 and 13 times more than CP20. CP411 was 2.5 times more effective than CP20 to mobilize iron from preloaded hepatocytes. Pretreatment of the hepatocytes with CP20 or CP411 decreased the toxic effect of iron and CP411 was 1.6 times more effective than CP20. A dose-dependent decrease of DNA synthesis, correlated to an accumulation of cells in S phase, was observed in the Fao cell line in the presence of CP411, while CP20 was without effect. CP411 effect was inhibited by addition of iron simultaneously with the chelator, the addition of Zn or Cu was without effect. The inhibitory effect of CP411 was reversible since, 24hr after removal of the chelator, DNA replication reached the control level. The results show that CP411 is more efficient to protect the hepatocyte from the toxic effect of iron load and to inhibit tumor cell proliferation. Its higher efficiency may result from its better cell uptake since equimolar solutions of the two chelators in an acellular system exhibit the same ability to inhibit the Fenton reaction.

摘要

本研究分析了亲脂性羟基吡啶酮CP411的铁动员、细胞保护和抗增殖作用,并与用于治疗铁过载的亲水性螯合剂CP20或去铁酮进行比较。使用了原代大鼠肝细胞培养物和大鼠肝癌细胞系Fao。通过质谱法在两种模型中评估螯合剂的细胞摄取。该方法还用于研究螯合剂在无细胞系统中的稳定性及其对芬顿反应产生的羟基自由基的清除和螯合作用。通过分别测量培养基中的55Fe和乳酸脱氢酶释放,在原代培养物中评估螯合剂的铁动员和细胞保护作用。使用Fao细胞系并通过胸苷掺入测量DNA合成以及通过流式细胞术测量DNA含量来研究螯合剂的抗增殖作用。我们观察到CP411进入肝细胞和Fao细胞的量分别比CP20多4倍和13倍。CP411从预加载的肝细胞中动员铁的效率比CP20高2.5倍。用CP20或CP411预处理肝细胞可降低铁的毒性作用,且CP411的效果比CP20高1.6倍。在存在CP411的情况下,Fao细胞系中观察到DNA合成呈剂量依赖性下降,这与细胞在S期的积累相关,而CP20则无作用。同时加入铁与螯合剂可抑制CP411的作用,加入锌或铜则无作用。CP411的抑制作用是可逆的,因为在去除螯合剂24小时后,DNA复制达到对照水平。结果表明,CP411在保护肝细胞免受铁负荷毒性作用和抑制肿瘤细胞增殖方面更有效。其更高的效率可能源于其更好的细胞摄取,因为在无细胞系统中两种螯合剂的等摩尔溶液表现出相同的抑制芬顿反应的能力。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验